---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-021848"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:28:25.081124+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Globus Medical to acquire Nevro for $5.85/sh in all-cash deal valued at ~$250M

## Summary
- All-cash transaction at $5.85/share; 27% premium to 90-day VWAP of $4.61.
- Total equity value approx. $250M; expected close by late Q2 2025.
- Globus Medical expects Nevro acquisition to be accretive to earnings in second year.
- Globus reaffirms standalone 2025 net sales guidance $2.66-$2.69B; combined guidance $2.80-$2.90B.
- Preliminary 2024 revenue: Globus $2.52B (+60.6% YoY); Nevro $408-$409M.

## SEC filing metadata
- accession: 0001193125-25-021848
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000119312525021848/0001193125-25-021848-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000119312525021848/d849414d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-021848
- JSON: https://secwatch.observer/filing/0001193125-25-021848.json
- Plain text: https://secwatch.observer/filing/0001193125-25-021848.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.